Frontlight ResearchEarly access
Amyloidosis trials in New Zealand
1 of 3 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Enrolling by invitationLong-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001
- Where
- Auckland
- Age
- 18 years and over
- People
- 72 worldwide
- Run by
- Intellia Therapeutics
See details and how to joinNCT05697861 · EU 2023-507385-11-00